Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David O Meltzer

Showing results (21-30 of 222) with videos related to

Pageof 23
Sort By:
Plos One|August 14, 2025
Longitudinal progression of cost-related medication non-adherence among Medicare patients with diabetes at high risk of hospitalization: The role of dual eligibilityJames X Zhang, David O Meltzer
JAMA|November 3, 2010
The real meaning of rationingDavid O Meltzer, Allan S Detsky
JAMA|November 12, 2009
Estimate of the carbon footprint of the US health care sectorJeanette W Chung, David O Meltzer
Health Affairs (Project Hope)|May 7, 2014
Redesigning care for patients at increased hospitalization risk: the Comprehensive Care Physician modelDavid O Meltzer, Gregory W Ruhnke
Health Affairs (Project Hope)|April 9, 2014
Quality indicators: the authors replyDavid O Meltzer, Jeanette W Chung
Health Affairs (Project Hope)|July 23, 2009
Comparative effectiveness research for antipsychotic medications: how much is enough?David O Meltzer, Anirban Basu, Herbert Y Meltzer
Journal of Palliative Medicine|May 6, 2008
Patient preferences in instructional advance directivesElmer D Abbo, Sarah Sobotka, David O Meltzer
Journal of the American Pharmacists Association : Japha|July 5, 2005
Consumers' perceptions about risk of and access to nonprescription medicationsG Caleb Alexander, Nadiah Mohajir, David O Meltzer
Advances in Health Economics and Health Services Research|November 20, 2012
How do initial signals of quality influence the diffusion of new medical products? The case of new cancer drug treatmentsRena M Conti, Arielle Bernstein, David O Meltzer
JAMA Internal Medicine|April 9, 2014
Actual involvement vs preference for involvement as an indicator of shared decision making-replyDavid O Meltzer, Gregory W Ruhnke, Hyo Jung Tak
Pageof 23

Showing results (21-30 of 222) with videos related to

Sort By:
Pageof 23
Plos One|August 14, 2025
Longitudinal progression of cost-related medication non-adherence among Medicare patients with diabetes at high risk of hospitalization: The role of dual eligibilityJames X Zhang, David O Meltzer
JAMA|November 3, 2010
The real meaning of rationingDavid O Meltzer, Allan S Detsky
JAMA|November 12, 2009
Estimate of the carbon footprint of the US health care sectorJeanette W Chung, David O Meltzer
Health Affairs (Project Hope)|May 7, 2014
Redesigning care for patients at increased hospitalization risk: the Comprehensive Care Physician modelDavid O Meltzer, Gregory W Ruhnke
Health Affairs (Project Hope)|April 9, 2014
Quality indicators: the authors replyDavid O Meltzer, Jeanette W Chung
Health Affairs (Project Hope)|July 23, 2009
Comparative effectiveness research for antipsychotic medications: how much is enough?David O Meltzer, Anirban Basu, Herbert Y Meltzer
Journal of Palliative Medicine|May 6, 2008
Patient preferences in instructional advance directivesElmer D Abbo, Sarah Sobotka, David O Meltzer
Journal of the American Pharmacists Association : Japha|July 5, 2005
Consumers' perceptions about risk of and access to nonprescription medicationsG Caleb Alexander, Nadiah Mohajir, David O Meltzer
Advances in Health Economics and Health Services Research|November 20, 2012
How do initial signals of quality influence the diffusion of new medical products? The case of new cancer drug treatmentsRena M Conti, Arielle Bernstein, David O Meltzer
JAMA Internal Medicine|April 9, 2014
Actual involvement vs preference for involvement as an indicator of shared decision making-replyDavid O Meltzer, Gregory W Ruhnke, Hyo Jung Tak
Pageof 23